IL147350A0 - Neurotrophic factor receptor - Google Patents

Neurotrophic factor receptor

Info

Publication number
IL147350A0
IL147350A0 IL14735000A IL14735000A IL147350A0 IL 147350 A0 IL147350 A0 IL 147350A0 IL 14735000 A IL14735000 A IL 14735000A IL 14735000 A IL14735000 A IL 14735000A IL 147350 A0 IL147350 A0 IL 147350A0
Authority
IL
Israel
Prior art keywords
receptor
factor receptor
neurotrophic factor
nucleic acid
acid sequence
Prior art date
Application number
IL14735000A
Other languages
English (en)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL147350A0 publication Critical patent/IL147350A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Psychology (AREA)
  • Biotechnology (AREA)
  • Plant Pathology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Microbiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
IL14735000A 1999-06-29 2000-05-26 Neurotrophic factor receptor IL147350A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9915200.1A GB9915200D0 (en) 1999-06-29 1999-06-29 Neurotrophic factor receptor
PCT/EP2000/004918 WO2001002557A1 (en) 1999-06-29 2000-05-26 Neurotrophic factor receptor

Publications (1)

Publication Number Publication Date
IL147350A0 true IL147350A0 (en) 2002-08-14

Family

ID=10856284

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14735000A IL147350A0 (en) 1999-06-29 2000-05-26 Neurotrophic factor receptor
IL147350A IL147350A (en) 1999-06-29 2001-12-27 Neurotrophic factor receptor

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL147350A IL147350A (en) 1999-06-29 2001-12-27 Neurotrophic factor receptor

Country Status (17)

Country Link
US (2) US7022818B1 (de)
EP (1) EP1196560B1 (de)
JP (1) JP4810036B2 (de)
KR (1) KR100676229B1 (de)
AT (1) ATE335079T1 (de)
AU (1) AU779486B2 (de)
CA (1) CA2377607C (de)
DE (1) DE60029791T2 (de)
DK (1) DK1196560T3 (de)
ES (1) ES2269157T3 (de)
GB (1) GB9915200D0 (de)
IL (2) IL147350A0 (de)
NO (1) NO332214B1 (de)
NZ (1) NZ515569A (de)
PT (1) PT1196560E (de)
WO (1) WO2001002557A1 (de)
ZA (1) ZA200110475B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045610B2 (en) * 1998-04-03 2006-05-16 Epoch Biosciences, Inc. Modified oligonucleotides for mismatch discrimination
GB9915200D0 (en) 1999-06-29 1999-09-01 Janssen Pharmaceutica Nv Neurotrophic factor receptor
AU7103900A (en) * 1999-09-01 2001-03-26 Biogen, Inc. Ret ligand 5 (retl5) compositions and uses thereof
FI20000394A0 (fi) * 2000-02-21 2000-02-21 Airaksinen Matti GFRa4:n sukuisia tai siitä johdettuja aineita sekä niiden käyttö
CA2438574C (en) * 2001-02-15 2009-08-11 Hiroaki Sagawa Method of detecting nucleotide polymorphism
US20070111201A1 (en) * 2001-04-30 2007-05-17 Benjamin Doranz Reverse transfection of cell arrays for structural and functional analyses of proteins
GB2386130A (en) * 2002-03-06 2003-09-10 Reckitt Benckiser Nv Detergent dosing delay device for a dishwasher
CN1688696A (zh) * 2002-09-18 2005-10-26 蒙特利尔大学医疗中心 Ghrh类似物
US9068182B2 (en) * 2009-07-28 2015-06-30 Corning Incorporated Synthetic polysaccharide microcarriers for culturing cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6222022B1 (en) 1996-03-14 2001-04-24 Washington University Persephin and related growth factors
ATE247667T1 (de) 1996-03-14 2003-09-15 Genentech Inc Gdnf-rezeptor und dessen verwendung
WO1999050298A1 (en) 1998-03-31 1999-10-07 Millennium Pharmaceuticals, Inc. GFRα-X, A NOVEL GLIAL-DERIVED NEUROTROPHIC FACTOR RECEPTOR AND USES THEREFOR
CA2335378A1 (en) * 1998-07-21 2000-02-03 Millennium Pharmaceuticals, Inc. Methods and compositions for the diagnosis and treatment of body weight disorders, including obesity
CN100480387C (zh) 1998-07-22 2009-04-22 范德比尔特大学 Gbs毒素受体
GB9915200D0 (en) 1999-06-29 1999-09-01 Janssen Pharmaceutica Nv Neurotrophic factor receptor

Also Published As

Publication number Publication date
NZ515569A (en) 2003-09-26
EP1196560B1 (de) 2006-08-02
US20060069242A1 (en) 2006-03-30
NO20020012D0 (no) 2002-01-02
US7476720B2 (en) 2009-01-13
AU5810200A (en) 2001-01-22
IL147350A (en) 2009-05-04
ZA200110475B (en) 2003-03-20
WO2001002557A1 (en) 2001-01-11
CA2377607A1 (en) 2001-01-11
DE60029791D1 (de) 2006-09-14
ATE335079T1 (de) 2006-08-15
PT1196560E (pt) 2006-12-29
US7022818B1 (en) 2006-04-04
KR20020069373A (ko) 2002-08-31
KR100676229B1 (ko) 2007-01-30
GB9915200D0 (en) 1999-09-01
CA2377607C (en) 2012-04-17
DE60029791T2 (de) 2007-10-18
JP4810036B2 (ja) 2011-11-09
ES2269157T3 (es) 2007-04-01
JP2003504017A (ja) 2003-02-04
DK1196560T3 (da) 2006-12-04
NO20020012L (no) 2002-02-27
EP1196560A1 (de) 2002-04-17
AU779486B2 (en) 2005-01-27
NO332214B1 (no) 2012-07-30
WO2001002557A8 (en) 2001-03-29

Similar Documents

Publication Publication Date Title
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
GR3006178T3 (de)
WO1998022574A3 (de) Rekombinante collagenase typ i aus clostridium histolyticum und ihre verwendung zur isolierung von zellen und zellverbänden
KR920701451A (ko) 인체혈청알부민의 n-말단 단편을 함유하는 융합 단백질
GB2147585B (en) Cdna clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity and/or mast cell growth factor activity
AU5020296A (en) C-C chemokine receptor 3: CKR-3 or EOS-l2
NZ506748A (en) Nucleic acids encoding a GFR alpha 3 polypeptide; host cell and vectors for production of the GRF alpha 3 protein and an assay for detecting GRFalpha 3 production
IL147350A0 (en) Neurotrophic factor receptor
WO1997000063A3 (en) Urocortin peptides
AU7873798A (en) N-terminally extended proteins expressed in yeast
JPS642572A (en) Polypeptide, dna and use thereof
EP0805204A3 (de) Nebenhoden-spezifisches Rezeptorprotein und dessen Verwendung
IL124939A0 (en) Vector for expression of n-terminally extended proteins in yeast cell
ZA978503B (en) Vertebrate smoothened proteins
Jean-Jean et al. Is there a human [psi]?
WO1997008317A3 (en) Human hypothalmic ('hr') receptor polypeptide compositions, methods and uses thereof
WO1995021916A3 (en) Pp32: a newly identified cd45-associated protein
DE60043664D1 (de) Dungen davon
NZ332555A (en) Gene expression in monocytes and macrophages associated with the CD68 gene
AU4744397A (en) A keratinocyte derived protease
WO1999055862A3 (en) Human proteins having transmembrane domains and dnas encoding these proteins
IT1297015B1 (it) Mutanti di rantes e loro applicazioni terapeutiche
IT1302012B1 (it) Derivati di rantes e loro applicazioni terapeutiche.
HUP0000653A2 (en) Mammalian chemokines